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Circadian physiology is responsible for the temporal regulation of metabolism to 2 
optimize energy homeostasis throughout the day. Disturbances in the light-dark cycle, 3 
sleep/wake schedule or feeding/activity behavior can affect the circadian function of the 4 
clocks located in the brain and peripheral tissues. These alterations have been associated 5 
with impaired glucose tolerance and type 2 diabetes. Animal models with molecular 6 
manipulation of clock genes and genetic studies in humans also support these links. It 7 
has been demonstrated that the endocrine pancreas has an intrinsic self-sustained clock, 8 
and recent studies have revealed an important role of clock genes in pancreatic beta-9 
cells, glucose homeostasis and diabetes. 10 
 11 
 12 




Type 2 diabetes and the circadian rhythm 16 
Type 2 diabetes has become one of the most important health problems of 17 
modern society, affecting millions of people worldwide. Obesity and excessive weight 18 
gain play a major role in the onset of diabetes, along with other risk factors including 19 
genetics and lack of physical activity. In recent years, circadian disturbances have also 20 
been identified as contributors to this metabolic disease. Alterations in circadian rhythm 21 
derived from our current lifestyle, such as mistimed sleeping, shift-working, or eating at 22 
abnormal night time hours, have been related to type 2 diabetes, obesity and metabolic 23 
syndrome [1-3]. The discovery of these associations opens new possibilities for the 24 
design of novel treatments for these metabolic disorders based on the appropriate 25 
alignment or resetting of the circadian system [4-6]. In the case of type 2 diabetes, its 26 
association to circadian disruption was originally related to an altered function of the 27 
central clock located in the hypothalamus. However, recent findings show that this 28 
disease can also be attributed to an impaired function of the endocrine pancreatic clock 29 
[7-10]. Thus, the study of the pancreatic clock biology is important not only to 30 
understand circadian rhythms and their relationship with metabolism, but also to 31 
develop tools for the prevention and therapy of metabolic diseases such as type 2 32 
diabetes.  33 
 34 
Central and peripheral clocks 35 
In mammals, the central pacemaker is located in the suprachiasmatic nuclei 36 
(SCN) in the hypothalamus. It is controlled by a transcriptional/translational 37 
autoregulatory feedback loop involving a set of clock genes (Figure 1). The core clock 38 
is composed of the transcription factors circadian locomotor output cycles kaput 39 
(CLOCK) and brain and muscle Arnt-like protein-1 (BMAL1), which bind to E-box 40 
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enhancers in the period (Per) and cryptochrome (Cry) promoters, producing PER and 41 
CRY expression [11,12]. PER and CRY proteins interact to form a complex that 42 
translocates to the nucleus and inhibits its own CLOCK:BMAL1-induced transcription. 43 
Phosphorylation of both proteins can also trigger their degradation by 26S proteasomes. 44 
The turnover of PER and CRY allows this cycle to continue. This clock network forms 45 
a self-sustained feed-back mechanism with an oscillatory pattern of approximately 24 46 
hours (Figure 1). Several proteins encoded by clock genes regulate the expression of 47 
down-stream targets that further regulate the clock machinery, function as clock-48 
controlled output genes relaying the clock information to down-stream proteins, or 49 
function in cellular processes such as metabolism. Another regulatory loop is composed 50 
by two nuclear receptor genes, which also possess an E-box enhancer activated by the 51 
CLOCK:BMAL1 heterodimer. REV-ERB ALPHA, so named because it is encoded by 52 
the reverse strand of the c-erb-A oncogene, can negatively regulate BMAL1 expression. 53 
In contrast, the retinoic-acid receptor-related orphan receptor alpha (ROR ALPHA) 54 
exerts a positive modulation of BMAL1 (Figure 1). Although the main input signal for 55 
this oscillator is the light/dark cycle, the SCN can receive additional information about 56 
nutrients and hormones as well [12]. It is also connected to a complex neural network 57 
with projections to different brain centers that regulate temperature, sleep, feeding, 58 
hormonal secretion and glucose homeostasis (Box1). 59 
In addition to the central clock in the brain, peripheral clocks with similar 60 
molecular components exist in several organs, such as liver, kidney, heart, adipose 61 
tissue and pancreas [8,10,11,13-18]. The link between the central and peripheral clocks 62 
was shown in studies in which the ablation of the SCN eliminated the synchrony of 63 
peripheral tissues, suggesting that the SCN maintains the phase alignment of the 64 
peripheral clocks [19,20]. The temporal alignment of the peripheral clocks is governed 65 
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hierarchically by the central clock dependent upon the light-dark cycles, allowing to 66 
optimize metabolism and energy homeostasis throughout the day. The alteration of 67 
circadian rhythms and/or the misalignment of peripheral clocks with the SCN may be 68 
related to the onset of different metabolic diseases including type 2 diabetes [3,21]. 69 
 70 
Circadian rhythms, metabolism and health 71 
Circadian variations in behavior and physiology are governed by internal 72 
biological clocks that are mainly regulated by light/dark inputs (sleep/activity cycles), 73 
but also by nutrient and hormonal signals [15,22,23] (Box 1). In addition to controlling 74 
the sleep/wake and feeding cycles, the circadian system regulates physiological 75 
processes such as lipid and glucose metabolism, body temperature, locomotor activity 76 
and hormone secretion [24], allowing the optimization of energy acquisition, use and 77 
storage throughout the day. Several parameters related to glucose metabolism such as 78 
glucose tolerance, insulin sensitivity as well as glucose, glucagon and insulin plasma 79 
levels are known to exhibit circadian variations along the day [25-30]. However, the 80 
regulation of this rhythmicity in glucose metabolism is still not well understood. 81 
Particularly, it is not totally clear how the interplay of all these factors that undergo 24 82 
hour variations can modulate daily changes in plasma glucose levels [31]. For instance, 83 
plasma glucose concentrations and glucose uptake are maximal at the beginning of the 84 
activity period in animals or around awakening in humans and, almost simultaneously, 85 
glucose production is high [31]. At night, however, glucose tolerance in humans is 86 
decreased compared to the daytime, probably because of reduced insulin sensitivity 87 
[27,30,31].  88 
Although feeding activity is one of the most important factors in the control of 89 
plasma insulin levels (Box 2), oscillations in plasma insulin are also reported during 90 
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day/night cycles in animals and humans independent of fasting/feeding behavior [32-91 
34]. In humans, during the daytime there is a peak of insulin secretion to increase 92 
energy storage and utilization [24,32,33]. Reduced insulin secretion and increased 93 
glucose production are favored at night [24]. In rodents, this pattern is shifted 12 hours 94 
according to their nocturnal activity [25]. 95 
Circadian rhythms can be disrupted by impaired function of biological clocks as 96 
well as by desynchronization between the SCN and the external environment or the 97 
peripheral clocks. This may lead to unfavorable health effects and the development of 98 
diseases such as metabolic syndrome, obesity and type 2 diabetes [35]. Current lifestyle 99 
and social habits, such as eating or working at night, being exposed to artificial light at 100 
night and altered sleeping schedules are among the factors that can cause circadian 101 
disruption. Shift workers, who are a paradigmatic model of circadian misalignment, 102 
have alterations in the pancreatic beta-cell responses and in glucose and lipid 103 
metabolism [3,36,37], as well as an increased risk of developing metabolic syndrome, 104 
cardiovascular disease, cancer, obesity and type 2 diabetes [37-41]. Individuals with 105 
altered or restricted sleep exhibit an increased body mass index, impaired glucose 106 
tolerance and reduced insulin responsiveness [42-44]. In obese individuals or patients 107 
with type 1 or type 2 diabetes, the circadian rhythms and magnitude of insulin secretion 108 
and sensitivity as well as glucose tolerance are impaired [45]. Some of these changes 109 
have also been observed in diabetic patients subjected to sleep deprivation [42,46,47]. 110 
Thus, alterations in circadian rhythms may lead to metabolic disturbances that could 111 
predispose to diabetes. 112 
 113 
Clock genes and metabolism: implications for glucose homeostasis and type 114 
2 diabetes  115 
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Animal models with manipulated clock genes have revealed that circadian 116 
rhythms have a key regulatory function in metabolism and glucose homeostasis. These 117 
animal models have also shown that impaired function of clock genes may result in 118 
prediabetic conditions or overt diabetes. Some evidence of this was first found in Clock 119 
mutant mice studies [48]. These mice had disrupted rhythms in feeding and locomotor 120 
activity, hyperphagia, hyperlipidemia, hyperglycemia and hypoinsulinemia. Studies 121 
performed in mice deficient in Bmal1 showed altered adipogenesis and hepatic 122 
carbohydrate metabolism [49-51]. While global inactivation of Bmal1 suppressed the 123 
diurnal variation in glucose and triglycerides and led to impaired gluconeogenesis and 124 
recovery from insulin-induced hypoglycaemia [50], liver-specific deletion of this clock 125 
gene resulted in hepatic clock dysfunction, fasting hypoglycemia and altered glucose 126 
clearance throughout the day [49]. Clear diabetic phenotypes characterized by 127 
hyperglycemia and hypoinsulinemia were demonstrated in Clock and Bmal1 mutants, as 128 
well as pancreas-specific Bmal1 knockout (KO) mice [8]. In these animal models, 129 
circadian clock gene expression was impaired in the endocrine pancreas. 130 
Several metabolic alterations have also been found in genetically manipulated 131 
animal models of CLOCK/BMAL1 downstream target genes. For instance, Per2 KO 132 
mice displayed normal circadian clock function in white adipose tissue but altered lipid 133 
metabolism [52], while Per3 single and Per1/2/3 triple KO mice showed altered body 134 
mass regulation when fed a high-fat diet (HFD) [53]. When both Cry1 and Cry2 were 135 
deleted, behavioral and molecular circadian rhythms were impaired, lipid and glucose 136 
metabolism were modified and glucose intolerance emerged [54-56]. Conversely, 137 
hepatic Cry1 over-expression in diabetic (db/db) mice led to increased insulin 138 
sensitivity and lower blood glucose levels [57]. It was also reported that cryptochrome 139 
proteins down-regulate liver gluconeogenesis during fasting by inhibition of glucagon-140 
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induced cAMP/protein kinase A signaling and cAMP response element-binding protein 141 
phosphorylation [57]. The use of synthetic CRY1/2 agonists inhibited glucagon-induced 142 
gluconeogenesis in primary hepatocytes [58]. 143 
Studies on mice lacking the nuclear receptors REV-ERB ALPHA OR ROR 144 
ALPHA revealed alterations in bile and lipid metabolism as well as decreased adiposity 145 
and HDL levels [59,60]. In the case of Rev-erb alpha KO mice, although these animals 146 
displayed alterations in the molecular clock oscillatory properties, they did not show 147 
arrhythmic behavior in a constant environment [60]. The link with lipid metabolism was 148 
also found in the double KO mice for Rev-erb alpha and beta [61]. These animals 149 
presented altered circadian wheel running behavior and disrupted circadian clock gene 150 
expression in the liver. When diet-induced obese mice were treated with REV-ERB 151 
agonists, these animals decreased fat mass and weight gain as well as triglyceride and 152 
cholesterol levels [6]. Interestingly, REV-ERB ALPHA over-expression in the liver also 153 
altered energy, and carbohydrate and lipid metabolism [62]. Thus, several studies using 154 
animal models support the role of clock genes in lipid and glucose homeostasis, and 155 
also indicate that their impaired function may lead to metabolic pathologies. 156 
In humans, genetic studies have also shown a link between clock genes and 157 
metabolism. For instance, genetic variants of CLOCK have been associated with 158 
increased susceptibility to total energy intake, obesity and metabolic syndrome [63-65]. 159 
BMAL1 genetic variants have been correlated with hypertension, and gestational and 160 
type 2 diabetes [66,67], while PER2 single-nucleotide polymorphisms have been 161 
associated with high fasting blood glucose levels and abdominal obesity [68,69]. CRY2 162 
variants have been related to type 2 diabetes and impaired fasting glucose [70,71]. A 163 
genetic polymorphism in the melatonin receptor, which plays a critical role in the 164 
modulation of the circadian rhythms, is also associated with increased susceptibility to 165 
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impaired insulin secretion and gestational and type 2 diabetes [72,73]. Thus, several 166 
genetic observations in humans point to the existence of a close link between clock gene 167 
dysfunction and pathological conditions such as metabolic syndrome, obesity and type 2 168 
diabetes. 169 
 170 
The role of clock genes in the pancreatic beta-cell function 171 
The endocrine pancreas is a complex organ composed of different cell types that 172 
regulate glucose metabolism according to physiological demands. The main pancreatic 173 
cells involved in glucose homeostasis are the insulin-secreting beta-cells and the 174 
glucagon-secreting alpha-cells (Box 2). The secretion of these two hormones is pulsatile 175 
and occurs within minutes after a nutrient challenge [74]. However, plasma insulin and 176 
glucagon levels have also been shown to exhibit 24 hour oscillations independent of 177 
feeding, as mentioned above [25,26,28,32,33]. Moreover, the deregulation of circadian 178 
insulin secretion and action has been identified in first-degree relatives of patients with 179 
type 2 diabetes, who exhibited decreased insulin secretion and glucose uptake [45]. The 180 
exact mechanism behind these circadian oscillations is still unknown. Although this 181 
pattern was originally believed to be exclusively regulated by neuronal signaling and 182 
the SCN [75], an intrinsic circadian oscillator controlling insulin secretion was 183 
discovered in the rat pancreas [76]. Later, it was shown that the mRNA levels of Per1, 184 
Per2, Bmal1, Clock and Rev-erb alpha in the pancreas oscillated throughout a 24-hour 185 
period [11]. Additionally, a high expression of the transcription factors and clock-186 
controlled output genes, d-binding protein (DBP) and thyrotroph embryonic factor 187 
(TEF), were shown to exist in human pancreatic islets and to have a circadian variation 188 
in insulin-secreting cells [77]. 189 
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The islet clock appears to consist of the same components as those of other 190 
peripheral clocks, exhibiting oscillations in their gene expression throughout the day in 191 
different species. A circadian clock gene expression has been shown in rat pancreas 192 
[11], mouse pancreas [78], mouse islets [8,10], human islets and dispersed human islet-193 
cells [79]. Additionally, it has also been observed in pancreatic cell lines such as MIN6 194 
cells [10], INS-1 cells [80] and alphaTC1-9 cells [81]. DBP has also been found to 195 
oscillate in the pancreatic cell line MIN6 and in mouse islets [82]. All these findings 196 
support the existence of an intrinsic clock within the pancreatic islet. 197 
Studies performed in whole-body, pancreas-specific and beta cell-specific KO 198 
mice have revealed the importance of islet clock genes in the control of insulin secretion 199 
and the development of diabetes. Additionally, these investigations have shown some of 200 
the potential mechanisms involved. Clock∆19/∆19 mutant mice, as well as pancreas-201 
specific Bmal1 KO mice, exhibit hyperglycemia, hypoinsulinemia and glucose 202 
intolerance [8]. This diabetic phenotype has been associated with altered insulin 203 
secretory responses. Pancreatic islets isolated from Clock mutant mice had reduced size 204 
and impaired insulin release [8]. Consistent with these findings, these pancreatic islets 205 
presented decreased beta-cell proliferation as well as reduced expression or changes in 206 
the circadian pattern of different genes involved in glucose uptake and metabolism, 207 
insulin signaling, cell cycle and beta-cell growth [8] (Figure 2). In the same way, Clock 208 
antisense treatment during pancreatic embryogenesis resulted in changes of different 209 
cell cycle proteins via WNT and NOTCH signaling [83]. Analysis of insulin release in 210 
isolated islets from Clock∆19/∆19 mice revealed impaired secretion in response to glucose 211 
but also to non-metabolic stimuli, indicating that defective exocytosis rather than altered 212 
glucose metabolism was likely involved [8]. The lack of changes in glucose-induced 213 
Ca2+ signaling (which precedes insulin secretion) as well as the decreased expression of 214 
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proteins involved in vesicle transport and docking, like VAMP3 and SYNTAXIN6, 215 
further supported this specific defect in beta-cell exocytosis.  216 
Similar alterations in insulin secretion were observed in isolated islets of whole-217 
body Bmal1 KO and pancreas-specific Bmal1 KO mice [8]. Another study reported 218 
hyperglycemia and hypoinsulinemia in global Bmal1 KO mice and demonstrated that 219 
the impaired glucose tolerance in this animal model was due to defective first phase 220 
insulin secretion [84]. Both isolated islets from these KO mice and INS-1 cells with 221 
Bmal1 knockdown exhibited a disrupted glucose-induced increase in the mitochondrial 222 
membrane potential gradient due to enhanced uncoupling protein 2 (Ucp2) expression, 223 
which led to decreased ATP levels and insulin secretion [84]. Inhibition of UCP2 224 
partially reversed these defects. In contrast to the findings in Clock∆19/∆19 mice [8], these 225 
latter results pointed to defects in glucose metabolism rather than alterations in 226 
exocytosis.  227 
These dissimilar effects might be due to different CLOCK and BMAL1 228 
pleiotropic actions in addition to their circadian role. A similar diabetic phenotype and 229 
secretion defects were reported in beta-cell specific Bmal1 KO mice [85]. This latter 230 
study indicated that BMAL1 is important for the prevention of oxidative stress. 231 
Pancreatic islets isolated from these mice displayed augmented reactive oxygen species, 232 
increased Ucp2 expression and impaired glucose-induced insulin release [85] (Figure 233 
2). Oxidative stress prevention or UCP2 suppression were able to reverse these defects. 234 
Additionally, it was shown that the key antioxidant regulatory factor Nrf2 was a direct 235 
target of BMAL1. In agreement with these reports, selective pancreas deletion of Bmal1 236 
also produced glucose intolerance and defective insulin secretion in mice and isolated 237 
islets [86].  238 
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In addition to the core clock components Clock and Bmal1, other clock genes 239 
such as Rev-erb alpha are also important for the pancreatic beta-cell function. Rev-erb 240 
alpha is expressed in pancreatic islets and exhibits circadian oscillations in MIN6 cells 241 
[10]. When this gene was silenced in mouse pancreatic islets, glucose-induced insulin 242 
secretion and beta-cell proliferation decreased [10]. Similarly, Rev-erb alpha exhibited 243 
circadian changes in alphaTC1-9 cells and, when it was down-regulated, glucose-244 
modulated glucagon secretion became impaired [81]. The effect of Rev-erb alpha on 245 
both beta and alpha-cell secretion may be related to the exocytotic process, as 246 
expression of exocytotic genes like Vamp3, Syntaxin1, Munc18 and Snap25 were 247 
decreased when Rev-erb alpha was silenced [81], in agreement with previous results in 248 
Clock∆19/∆19 mice [8]. Thus, although further work is necessary to understand the 249 
regulatory networks, it seems that clock genes may influence beta-cell mass and 250 
function by modulation of different processes (Figure 2). 251 
Interestingly, in addition to clock genes, the expression of several other genes 252 
exhibits a circadian rhythm in the pancreas, isolated islets and beta-cell lines. These 253 
genes include Glut2, Glucokinase, Syntaxin1A, Insulin, Ucp2, Nrf2, CyclinD1, Pdx1 and 254 
other genes involved in beta-cell metabolism, secretion, growth and insulin signaling 255 
[77,87]. It has been reported that Nrf2 is a transcriptional target of BMAL1 [85], TEF 256 
transactivates Glut2 by direct interaction with the promoter [77] and DBP directly 257 
increases the transcription of Arnt/Hif1beta [82], a key gene in beta-cell metabolism and 258 
secretion (Figure 2). It would be interesting to know whether the circadian expression of 259 
all these above-mentioned genes is coupled to an oscillatory functional output in 260 
different beta-cell processes. In this regard, there is a high correlation between the 261 
diurnal changes in insulin secretion and the glucose-induced reduction in beta-cell K+ 262 
conductance, most likely via ATP-dependent K+ channel inhibition, which was 263 
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measured at the same time of the day [88]. Likewise, a circadian expression of 264 
functional K+ channels has been reported in rat pancreatic islets [89]. 265 
The information about clock genes in human islets is scarce. Human islets also 266 
express BMAL1, CLOCK, PER1, PER2, PER3, CRY1 and CRY2, and have been found 267 
to exhibit self-sustained circadian oscillations of Bmal1-luciferase expression [79]. 268 
Islets from type 2 diabetes patients have decreased CRY2, PER2 and PER3 expression, 269 
which positively correlated with insulin content [90]. Additionally, the exposure of 270 
human pancreatic islets to high glucose and palmitate levels decreased PER3 expression 271 
[90]. Although various animal studies support that clock genes have an essential 272 
function in the endocrine pancreas, further research will be required to unravel their role 273 
in the human pancreas.  274 
 275 
Environmental conditions that alter circadian rhythms and the pancreatic clock 276 
Current lifestyle frequently involves alterations in the natural rhythms governed 277 
by the circadian system and the daily light/dark cycle. Diet composition as well as 278 
eating and activity at inappropriate times, which can disrupt circadian clocks, have been 279 
related to type 2 diabetes [40,41,91]. Although sleep loss has also been associated with 280 
this disease [43,44,47], recent studies indicate that circadian misalignment induced by 281 
changing the sleeping schedules can also increase diabetes risk independent of sleep 282 
loss [21]. SCN ablation affects the circadian pattern of glucose tolerance, as well as 283 
glucose, insulin and glucagon plasma levels [26-28], suggesting that this central clock 284 
plays an important role in glucose homeostasis. However, several environmental factors 285 
can also affect the function of these circadian oscillators not only in the SCN, but also in 286 
peripheral locations (Box1). 287 
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In recent mouse studies, constant exposure to light or a HFD or combination of 288 
both altered the SCN function, affecting the circadian patterns of feeding, energy 289 
expenditure and insulin sensitivity [92]. Experiments with mice fed a HFD have shown 290 
changes in the circadian expression of clock genes and clock-regulated metabolic genes 291 
in the hypothalamus, liver, and adipose tissue [16]. Additionally, mice fed a HFD 292 
during the light phase gained more weight than those fed during the dark phase [93]. 293 
Temporal feeding restriction in mice produced a misalignment between the SCN and 294 
the peripheral clocks in liver, kidney, heart, and pancreas, but did not affect the 295 
circadian behavior of the central clock [94]. In contrast, caloric restriction can affect 296 
both central and peripheral clocks [95]. Simulated shift work in rats led to abdominal 297 
obesity and dampened glucose rhythms. Both alterations were reversed when the 298 
feeding time was shifted back to the activity phase [96]. The majority of these results 299 
show the importance of appropriate feeding timing for the maintenance of circadian 300 
function. Thus, feeding schedules uncoupled from natural day/night cycles can lead to 301 
altered circadian rhythms and lack of synchrony between central and peripheral clocks 302 
that may favor metabolic diseases. 303 
The effect of some of these environmental factors has also been analyzed in the 304 
endocrine pancreas. The effect of light exposure at night has been investigated in the rat 305 
pancreas using Per1-driven luciferase [97]. While changes in the light/dark cycle in vivo 306 
entrained the phase of islet clock transcriptional oscillations, ten weeks of continued 307 
exposure to light at night (constant light regime over 24 hours) impaired the amplitude, 308 
phase, and inter-islet synchrony of clock transcriptional oscillations. In these 309 
circumstances, glucose-stimulated insulin secretion was impaired due to a decrease in 310 
the insulin secretory pulse mass [97]. Interestingly, it was also observed that glucose 311 
regulates the amplitude and period of Per1 circadian oscillations, indicating a nutrient-312 
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sensing mechanism in the islet clock. It has also been reported that constant light regime 313 
or 6-h advance of the light cycle every 3 days accelerates the development of diabetes in 314 
Sprague Dawley rats transgenic for the human islet amyloid polypeptide [7]. Exposure 315 
to HFD has been shown to change the circadian expression pattern of Rev-erb alpha, 316 
Clock, Per1 and Per2 in mouse pancreatic islets as well as the circadian insulin 317 
secretion [10]. Circadian misalignment by simulation of shift work induced oxidative 318 
stress and altered insulin release in pancreatic islets similar to that observed in beta-cell 319 
specific Bmal1 KO mice [85]. Thus, several studies have demonstrated that 320 
environmental conditions that affect circadian rhythms can also impair the pancreatic 321 
clock and the function of this endocrine organ.  322 
 323 
Conclusions and future perspectives 324 
 Numerous studies have revealed an association between alterations in human 325 
circadian rhythms and metabolic diseases such as type 2 diabetes. Moreover, animal 326 
models with genetically manipulated clock genes, as well as genetic studies in humans, 327 
have further demonstrated a link between clock genes and glucose homeostasis. 328 
Although glucose metabolism and its circadian variations may depend on several 329 
tissues and factors, which also present daily activity oscillations, the demonstration of 330 
an existing self-sustained circadian clock in the endocrine pancreas is of critical 331 
importance. Indeed, several animal models with an ablated function of different clock 332 
genes, either in the whole body, the pancreas or beta-cells, exhibit diabetic phenotype 333 
features including glucose intolerance, hyperglycemia and/or hypoinsulinemia. 334 
Additionally, the pancreatic islets from these animal models show impaired exocytosis 335 
and insulin release, altered mitochondrial function and alterations in cell proliferation 336 
or cell size. Several of these observations have also been reported in human islets. It has 337 
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been recently demonstrated that the pancreatic clock and islet function are also affected 338 
by some environmental factors known to disrupt circadian rhythms. It could therefore 339 
be concluded that the pancreatic clock plays an important role in the endocrine pancreas 340 
function and in glucose homeostasis, and that its malfunction may lead to glucose 341 
intolerance and type 2 diabetes. Since the research focused on the pancreatic clock is 342 
relatively new, there are yet important questions to be answered (Box 3).  343 
 Understanding the role of the pancreatic clock may help in the design of 344 
therapeutic interventions for metabolic diseases such as type 2 diabetes, when they are 345 
a consequence of circadian alterations. For instance, since Cry1 over-expression in 346 
diabetic mice increased insulin sensitivity and lowered blood glucose levels [57], it 347 
would be interesting to explore the role of CRY1/2 agonists in the treatment for 348 
diabetes. In this regard, the agonist KL001 was proved to be useful in preventing the 349 
glucagon-mediated activation of hepatic glucose production, which could be beneficial 350 
in the control of fasting glucose levels [58]. The use of REV-ERB agonists may also be 351 
valuable for the treatment of diabetes and obesity, since these molecules enhance 352 
energy expenditure, reduce fat mass and improve dyslipidaemia and hyperglycemia in 353 
diet-induced obese mice [6]. ROR GAMMA antagonists have been recently suggested 354 
to be a therapeutic strategy in type 2 diabetes by modulation of insulin resistance and 355 
glucose tolerance [98]. Other potential drugs to be explored in metabolic diseases could 356 
include ligands for ROR ALPHA [99-101] as well as for other components of the 357 
central clock [91]. Although several of these ligands, agonists and antagonists modulate 358 
metabolic processes in peripheral clocks located in the liver, adipose tissue and muscle, 359 
their actions in the pancreatic clock remain to be explored.  360 
 Taking into consideration the pancreas chronobiology also implies evaluating 361 
the appropriate daily times for medical treatments in diabetic patients or for the 362 
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evaluation of glycemic parameters. In this regard, recent clinical studies have shown 363 
that there exists a circadian variation in the response to the glucose challenge test in 364 
pregnancy, which may influence the diagnosis of gestational diabetes [102]. In 365 
addition, it would be important to analyze whether alterations of circadian rhythms (i.e. 366 
shift work) affect the human pancreatic clock and function. If so, it would be also 367 
interesting to evaluate whether life style changes adapted to the natural light/dark cycle 368 
and to appropriate feeding and activity times have a positive impact on the pancreas 369 
clock in terms of preventing and treating metabolic diseases such as diabetes. 370 
 371 
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Box 1. The central and peripheral clocks. 381 
Numerous biological processes such as body temperature, feeding/fasting and 382 
sleep/wake behavior, as well as hormonal release, display circadian patterns which are 383 
mainly driven by the central clock located in the suprachiasmatic nuclei (SCN) of the 384 
hypothalamus. These circadian rhythms are responsible for the optimization of energy 385 
homeostasis throughout the light/dark cycle of the day. The neuronal population that 386 
forms this master clock works as a self-sustained circadian oscillator that is controlled 387 
by autoregulated transcriptional feedback loops. The SCN also sends neural projections 388 
to other brain areas that are important for the regulation of sleep, feeding, energy 389 
homeostasis and temperature [22]. Several external cues (also called zeitgebers) 390 
synchronize the internal clocks to 24 hour cycles. The change of environmental light 391 
throughout the day/night cycle is the main entraining signal for the SCN, which in turn 392 
also synchronizes other clocks located in extra-SCN brain areas and peripheral tissues to 393 
the photic signals [103]. Additionally, other external cues like the time of 394 
feeding/fasting or food restriction can also affect the circadian rhythm of internal 395 
clocks. Different metabolic sensors can integrate information from the nutritional state 396 
and transfer it to the clock machinery. In this way, changes in NAD/NADH or 397 
AMP/ATP during exercise, fasting or caloric restriction can be sensed by the clocks 398 
[22].  399 
 Peripheral tissues are also equipped with autonomous clock oscillators with 400 
similar molecular components as those of the SCN. The circadian activity of these 401 
peripheral clocks is temporally aligned to the central SCN clock mainly by autonomic 402 
innervations, hormonal signals (i.e. glucocorticoids) and feeding-related cues [103]. Just 403 
as the central pacemaker, peripheral clocks contribute to global energy metabolism but 404 
also participate in local metabolic functions such as those involved in glucose and lipid 405 
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homeostasis. Although light-dependent time alignment with the SCN is important, the 406 
fasting/feeding cycles and changes in several nutritional factors also play an important 407 
role in the entrainment of peripheral clocks [22]. For instance, a high-fat diet and caloric 408 
restriction affect both peripheral and central clocks, while temporal feeding restriction 409 




Box 2. Endocrine pancreas function and type 2 diabetes.  413 
The endocrine pancreas is composed of a heterogeneous collection of cell types 414 
that form the islets of Langerhans, which are dispersed throughout the whole pancreatic 415 
tissue. The main cell types are the insulin-secreting beta-cells and the glucagon-416 
releasing alpha-cells. These cell populations respond reciprocally to plasma glucose 417 
levels [104]. While beta-cells secrete insulin at increasing glucose concentrations, 418 
alpha-cells release glucagon at lower glucose levels. Insulin mainly acts through the 419 
PI3K (phosphatidylinositol-4,5-bisphosphate 3-kinase) pathway in muscle and adipose 420 
tissue to induce glucose uptake, and in the liver to reduce hepatic glucose production. 421 
These processes result in decreased plasma glucose levels. In contrast, glucagon mainly 422 
binds to liver receptors, activating gluconeogenesis and glycogenolysis via the protein 423 
kinase A pathway, which allows for an increase in plasma glucose levels. Thus, glucose 424 
is maintained within a physiological range by the fine regulation of islet secretion [104].  425 
Type 2 diabetes results from insulin resistance along with impaired beta-cell 426 
function. In this condition, insulin action is attenuated, leading to decreased insulin-427 
induced glucose uptake in the adipose tissue and muscle as well as enhanced hepatic 428 
glucose production [105]. In the majority of individuals, insulin resistance induces a 429 
compensatory adaptation in the pancreas, resulting in an augmented beta-cell mass and 430 
function to increase insulin release, which ensures the maintenance of normoglycemia. 431 
However, when this beta-cell compensation is insufficient, hyperglycemia may 432 
progressively develop. This deficient adaptive response can be also accompanied by 433 
beta-cell failure and loss. It has been suggested that hyperglucagonemia and alpha-cell 434 
dysfunction are also involved in the pathophysiology of type 2 diabetes, and may 435 




Box 3. Outstanding questions.  439 
- What is the exact contribution of the pancreatic clock to glucose homeostasis and 440 
the daily variations in plasma glucose and insulin? 441 
- Which mechanisms allow for the communication between the SCN and the 442 
pancreatic clock?  443 
- Is the misalignment of the pancreatic clock with the SCN sufficient to induce 444 
alterations in glucose homeostasis and diabetes? 445 
- Will pharmacological modulation of the clock proteins lead to useful therapeutics 446 
to treat metabolic diseases? 447 
- Which environmental factors known to produce circadian disruption are able to 448 
affect the pancreatic clock and the function of this organ? What are the mechanisms? 449 
- Could the reversal of or the intervention in these environmental factors restore the 450 
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FIGURE LEGENDS 702 
Figure 1. Feedback loop in the core circadian clocks. The clock machinery is 703 
composed of different feedback loops. In the primary loop, BMAL1 and CLOCK drive 704 
the transcriptional expression of Per and Cry through the activation of E-box enhancers. 705 
PER and CRY proteins form heterodimers that translocate to the nucleus, repressing 706 
their own transcription by interaction with CLOCK:BMAL1 complexes. The turnover 707 
of PER and CRY is also regulated by protein casein kinase 1 and AMP kinase, which 708 
phosphorylate these proteins, inducing their degradation in the cytosol by the 26S 709 
proteasome complex. This feedback in the primary loop occurs during 24 hours and 710 
then, a new cycle starts. In another loop, CLOCK:BMAL1 heterodimers drive the 711 
transcriptional expression of Rev-erb and Ror, which inhibit and activate Bmal1 712 
expression, respectively. Some clock-controlled genes (Ccgs), which are involved in 713 
metabolic pathways, are also under the modulation of the clock machinery.  714 
Abbreviations: BMAL1, brain and muscle ARNT-like 1; CLOCK, circadian locomotor 715 
output cycles protein kaput; PER, period homolog drosophila; CRY, cryptochrome; 716 
REV-ERB, reverse-eritroblastosis virus; RORS, retinoic acid receptor-related orphan 717 
receptor; RORE, ROR response element. 718 
 719 
Figure 2. Clock genes in the regulation of pancreatic beta-cell function. Glucose 720 
enters the pancreatic beta-cell via glucose transporter 2 (GLUT2) and is metabolized by 721 
mitochondria, resulting in the rapid generation of ATP and the subsequent closure of 722 
ATP-sensitive K+ (KATP) channels. The closure of these channels leads to plasma 723 
membrane depolarization (∆Vm), opening voltage-gated Ca2+ channels (VOCC). The 724 
consequent Ca2+ influx triggers insulin release through exocytosis of insulin secretory 725 
granules. Pancreatic beta-cell regulation by clock genes may involve several processes 726 
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and mechanisms. Impaired glucose-induced insulin secretion (GSIS) has been shown in 727 
islets deficient in CLOCK, BMAL1 or REV-ERB. CLOCK and REV-ERB may 728 
regulate insulin secretion by modulating the expression of genes involved in exocytosis 729 
(Vamp3, Syntaxin1, Munc18, Snap25). Additionally, CLOCK and REV-ERB regulate 730 
beta-cell proliferation, probably through the modulation of different genes involved in 731 
beta-cell survival and growth (CyclinD1, Hnf4α, InsR, Pdx1). BMAL1 is also required 732 
for normal beta-cell GSIS by reducing UCP2-mediated mitochondrial uncoupling and 733 
oxidative stress and by increasing antioxidant defenses. This latter action is mediated by 734 
direct transcriptional modulation of Nrf2 by BMAL1. The clock-controlled output 735 
proteins TEF and DBP have also been shown to directly modulate the transcriptional 736 
activity of the glucose transporter 2 (Glut2) and Arnt, respectively. This latter gene 737 
plays a key role in beta-cell metabolism and GSIS. 738 
Abbreviations: BMAL1, brain and muscle ARNT-like 1; CLOCK, circadian locomotor 739 
output cycles protein kaput; CRY, cryptochrome; DBP, d-binding protein; PER, period 740 
homolog drosophila; REV-ERB ALPHA, reverse-eritroblastosis virus alpha; TEF, 741 
thyrotroph embryonic factor; UCP2, uncoupling protein 2. 742 
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